Independent Journalism · Est. 2026
ACUMEN
World
National
Technology
Culture
Economy
Newsletter
For YouWorldNationalTechnologyCultureEconomyNewsletter
ACUMEN

Context-first journalism for a world overwhelmed by noise.

Get the App

Download for Android

Coverage

  • World
  • National
  • Technology
  • Economy
  • Culture
  • Newsletter

Company

  • About
  • Press
  • Ethics Policy
© 2026 Acumen News. All rights reserved.
PrivacyTermsCookies
Independent Journalism · Est. 2026
ACUMEN
World
National
Technology
Culture
Economy
Newsletter
For YouWorldNationalTechnologyCultureEconomyNewsletter
ACUMEN

Context-first journalism for a world overwhelmed by noise.

Get the App

Download for Android

Coverage

  • World
  • National
  • Technology
  • Economy
  • Culture
  • Newsletter

Company

  • About
  • Press
  • Ethics Policy
© 2026 Acumen News. All rights reserved.
PrivacyTermsCookies
Independent Journalism · Est. 2026
ACUMEN
World
National
Technology
Culture
Economy
Newsletter
For YouWorldNationalTechnologyCultureEconomyNewsletter
All Stories

Technology

1029 articles · sorted by newest first

AllAI & SocietyBig Tech & MarketsScience & SpaceCyber & Privacy

Latest in Technology

Latest in Technology
20 results
Technology 5/22/2026

Belgium: Full-Life Technologies raises US$150m to advance clinical stage assets

Full-Life Technologies, a cutting-edge radiotherapeutics company with significant operational hubs spanning Belgium, Germany, and China, has successfully secured a monumental US$150 million in a Series B financing round. This substantial capital infusion, led by the prominent healthcare investment firm Vivo Capital, is strategically earmarked to aggressively advance the company's robust pipeline of clinical stage assets. Full-Life specializes in the innovative development of radiopharmaceuticals, which are designed to deliver highly targeted radiation for the precise treatment of various oncology indications, marking a significant stride in the burgeoning field of precision medicine.

Editorial Team1 min
Belgium: Full-Life Technologies raises US$150m to advance clinical stage assets
Technology 5/22/2026

Fushi Tech Launches General-Purpose AI Agent for Overseas Merchants

Fushi Tech, a Singapore-based subsidiary of the prominent Hong Kong-listed fintech entity Yeahka (9923.HK), has unveiled Fynix AI Shop, an advanced general-purpose AI agent engineered specifically for overseas merchants. This strategic upgrade positions Fynix AI Shop as an autonomous digital employee, designed to seamlessly manage the entire customer lifecycle – from initial acquisition and conversion to payment processing and fostering repeat purchases. By embedding directly into a merchant's existing CRM system, the AI recognizes returning customers, provides instant personalized responses to inquiries via messaging apps, offers tailored product recommendations, and guides users through the sales funnel all the way to order completion. This move signifies a shift from conventional marketing tools to intelligent, self-executing business agents.

Editorial Team1 min
Fushi Tech Launches General-Purpose AI Agent for Overseas Merchants
Technology 5/22/2026

Scientists propose hemp-based biorefinery to produce green hydrogen, bioenergy and therapeutic cannabinoids

Scientists have unveiled a groundbreaking concept for an integrated hemp-based biorefinery designed to revolutionize the production of clean energy and high-value pharmaceuticals. This proposed model aims to process industrial hemp into green hydrogen, diverse bioenergy products like biofuels or electricity, and therapeutic cannabinoids—all from a single cultivation cycle. The core innovation lies in its "zero-waste" philosophy, ensuring every part of the crop is efficiently utilized, from lignocellulosic biomass for energy conversion via thermochemical or biochemical processes, to targeted extraction of specific compounds for medical applications. This holistic approach signals a significant step towards maximizing the economic and environmental utility of a rapidly re-emerging agricultural commodity.

Editorial Team1 min
Scientists propose hemp-based biorefinery to produce green hydrogen, bioenergy and therapeutic cannabinoids
Technology 5/22/2026

Cycling may significantly improve brain health and well-being

A recent peer-reviewed publication in *Frontiers in Sports and Active Living* has confirmed that cycling acts as a powerful, accessible intervention for significantly improving brain health and overall well-being. The study elaborates on the physiological mechanisms by which regular bicycling enhances cognitive function, bolstering aspects like working memory, executive control, and attentional focus. Key findings point to increased cerebral blood flow, enhanced neurogenesis in brain regions like the hippocampus, and boosted neuroplasticity, which collectively contribute to improved cognitive resilience and a reduced risk profile for neurodegenerative diseases. This research effectively consolidates existing evidence, providing a robust scientific underpinning for integrating cycling into public health strategies aimed at ameliorating cognitive decline and promoting mental health across diverse age demographics.

Editorial Team1 min
Cycling may significantly improve brain health and well-being
Technology 5/22/2026

Oral drug improves platelet recovery during chemotherapy in gastrointestinal cancer patients

Researchers from Sylvester Comprehensive Cancer Center at the University of Miami Miller School of Medicine and Mass General Hospital have announced promising results from a Phase 2 clinical trial. The study focused on Eltrombopag, an oral Thrombopoietin Receptor Agonist (TPO-RA) already approved for conditions like chronic idiopathic thrombocytopenia. In this new trial, Eltrombopag significantly improved platelet recovery and helped gastrointestinal cancer patients maintain adequate platelet counts, crucial for continuing scheduled chemotherapy without dose reductions or delays. This breakthrough addresses a critical challenge in oncology, where chemotherapy-induced myelosuppression often disrupts treatment protocols, impacting patient outcomes.

Editorial Team1 min
Oral drug improves platelet recovery during chemotherapy in gastrointestinal cancer patients
Technology 5/22/2026

Experimental virus therapy targets resistant high-grade neuroendocrine tumors

A groundbreaking Phase I clinical trial is underway, investigating an experimental oncolytic virus therapy designed to enhance immunotherapy effectiveness against resistant high-grade neuroendocrine tumors (NETs). This early-stage study aims to assess the safety and preliminary efficacy of using a genetically modified virus that selectively targets and lyses cancer cells, simultaneously stimulating an anti-tumor immune response. The trial focuses on patients with aggressive NETs, a notoriously difficult-to-treat cancer sub-type often characterized by high proliferation rates and limited response to conventional systemic therapies, including existing immunotherapies. This represents a critical pivot in oncology, moving towards novel combinatorial approaches to overcome entrenched treatment resistance.

Editorial Team1 min
Experimental virus therapy targets resistant high-grade neuroendocrine tumors
Technology 5/22/2026

Formosa Pharmaceuticals Announces Presentation of TSY-310 at the 2026 ASCO Annual Meeting

Formosa Pharmaceuticals has announced that its abstract highlighting the differentiated binding profile and preclinical efficacy of TSY-310, a novel bispecific antibody-drug conjugate (ADC), has been selected for presentation at the prestigious 2026 American Society of Clinical Oncology (ASCO) Annual Meeting. This upcoming presentation signifies a crucial milestone for the Taiwan-based biopharmaceutical firm, positioning TSY-310 as a promising candidate in the intensely competitive oncology drug development landscape and garnering attention within the global scientific community.

Editorial Team1 min
Formosa Pharmaceuticals Announces Presentation of TSY-310 at the 2026 ASCO Annual Meeting
Technology 5/22/2026

Study finds nearly 147,000 AI-generated fake citations in scientific papers across major research databases

A groundbreaking study has exposed nearly 147,000 AI-generated fake citations embedded within scientific papers across leading academic databases. This unprecedented surge in erroneous references is attributed to researchers misusing large language model (LLM) based AI chatbots, failing to verify the legitimacy of generated references before inclusion. Concurrently, arXiv, a pivotal open-access preprint server, has formally announced a ban on submissions containing such 'hallucinated citations,' signaling a critical pivot in safeguarding academic integrity.

Editorial Team1 min
Study finds nearly 147,000 AI-generated fake citations in scientific papers across major research databases
Technology 5/22/2026

Canadian regulator triples US streamers' financial contributions to Canadian content

The Canadian Radio-television and Telecommunications Commission (CRTC) has implemented a landmark policy, requiring major international streaming services like Netflix, Disney+, and Amazon Prime Video to allocate 15% of their Canadian gross revenues towards the creation and promotion of Canadian content (CanCon). This directive, effective September 2024 and enabled by the Online Streaming Act (Bill C-11), represents an unprecedented regulatory burden on these digital platforms, which previously operated largely outside such financial obligations. While not a literal tripling of a pre-existing mandated streamer contribution, the move dramatically increases their financial commitment from what was previously negligible or voluntary, aiming to inject hundreds of millions annually into Canada's domestic media ecosystem.

Editorial Team1 min
Canadian regulator triples US streamers' financial contributions to Canadian content
Technology 5/22/2026

Aktis Oncology Reports First-in-Human Clinical Imaging and Dosimetry Data for AKY-2519 Demonstrating Robust Tumor Uptake and Limited Normal Tissue Exposures in Patients with B7-H3 Expressing Tumors

Aktis Oncology (NASDAQ: AKTS) just dropped promising "first-in-human" data for their experimental cancer treatment, AKY-2519. This novel "miniprotein radioconjugate," engineered to precisely target "B7-H3 expressing tumors," demonstrated "robust tumor uptake"—meaning it's effectively hitting its intended target—while concurrently achieving "limited normal tissue exposures." Essentially, this groundbreaking approach is designed to deliver therapeutic radiation with high precision, minimizing collateral damage to healthy cells. These findings, derived from early "clinical imaging and dosimetry data" in patients with "mCRPC (Metastatic Castration-Resistant Prostate Cancer)" and other solid tumor types, are slated for prominent presentation at the highly anticipated 2026 ASCO Annual Meeting.

Editorial Team1 min
Aktis Oncology Reports First-in-Human Clinical Imaging and Dosimetry Data for AKY-2519 Demonstrating Robust Tumor Uptake and Limited Normal Tissue Exposures in Patients with B7-H3 Expressing Tumors
Technology 5/22/2026

Macrocyclic host molecules observed working together on a surface

A joint research team from Japan's Kanazawa University and Kyoto University has achieved a significant breakthrough, directly visualizing how densely assembled "macrocyclic host molecules" collaboratively capture "guest molecules" on a surface. Utilizing advanced "Atomic Force Microscopy (AFM)" techniques, the researchers successfully tracked both the formation of "host-guest complexes" and their reversible association-dissociation dynamics at the single-molecule level. This direct observation provides unprecedented insight into the intricate mechanisms of molecular recognition and self-assembly, laying foundational knowledge for future nanoscale engineering.

Editorial Team1 min
Macrocyclic host molecules observed working together on a surface
Technology 5/22/2026

OpenAI's Top-Safety Expert Departs Company: 'Not An Easy Decision'

Computer scientist Aleksander Madry, a key figure in OpenAI's safety initiatives, has announced his departure from the ChatGPT parent company after nearly three years. Madry, who initially joined OpenAI in 2021 and served as the head of its Preparedness team, focused on safeguarding against "catastrophic risks related to frontier AI models." He was later reassigned to a role concentrating on AI reasoning. His exit adds to a series of high-profile departures from OpenAI’s safety-centric divisions, most notably following the May 2024 resignations of co-founder Ilya Sutskever and Jan Leike from the Superalignment team, which was specifically tasked with controlling future superintelligent AI.

Editorial Team1 min
OpenAI's Top-Safety Expert Departs Company: 'Not An Easy Decision'
Technology 5/22/2026

One‐week radiotherapy course shown to be safe and effective in the long term for early‐stage breast cancer

Groundbreaking research from the FAST-Forward trial, spearheaded by Keele University oncologist Professor Murray Brunt and sponsored by The Institute of Cancer Research, London, has conclusively shown that a one-week course of post-surgical radiotherapy is as safe and effective as the traditional three-week regimen for individuals with early-stage breast cancer. This pivotal decade-long study, meticulously tracking over 4,000 patients, marks a significant paradigm shift in oncology, validating a condensed treatment schedule and offering a new standard for adjuvant therapy.

Editorial Team1 min
One‐week radiotherapy course shown to be safe and effective in the long term for early‐stage breast cancer
Technology 5/22/2026

A New Chipmaker Just Topped Micron's 2026 Return, Thanks To Nvidia

Arm Holdings plc, the British chip designer, just pulled off a staggering 38% surge in its stock price over three trading sessions, decisively outperforming Micron Technology Inc. and vaulting into second place in the year-to-date performance rankings of the iShares Semiconductor ETF (SOXX). This seismic shift was largely catalyzed by Nvidia Corp.’s blockbuster earnings report, which underscored the escalating demand for Artificial Intelligence (AI) Infrastructure. Further tailwinds included a bullish initiation report from Bernstein on May 18, and Arm’s own robust fourth-quarter fiscal 2024 earnings, demonstrating solid foundational growth.

Editorial Team1 min
A New Chipmaker Just Topped Micron's 2026 Return, Thanks To Nvidia
Technology 5/22/2026

Asteroid Impact Site Reveals Possible Traces Of Early Life

A South Korean research team from the Korea Institute of Geoscience and Mineral Resources (KIGAM) has made a groundbreaking discovery, suggesting that ancient impact-generated lakes may have been crucial cradles for the earliest forms of oxygen-producing life on Earth. Published in Nature Geoscience, their findings challenge conventional views by presenting evidence from an asteroid impact site, indicating these localized, hydrothermally active freshwater environments could have provided stable conditions for organisms capable of oxygenic photosynthesis, thereby accelerating the accumulation of atmospheric oxygen.

Editorial Team1 min
Asteroid Impact Site Reveals Possible Traces Of Early Life
Technology 5/22/2026

SpaceX Mania Hits ETFs: XOVR Raises Stake Ahead Of Blockbuster IPO

The scramble for pre-IPO exposure to SpaceX has reached a fever pitch, with ERShares' Private-Public Crossover ETF (XOVR) significantly bolstering its stake. The fund announced a fresh injection of approximately $35 million, elevating its total SpaceX position to roughly $281 million, which constitutes about 23% of its total assets under management. This aggressive move comes as SpaceX officially filed for its IPO late Wednesday, with reports suggesting a Nasdaq debut as early as June 12 under the ticker SPCX. This development underscores a broader institutional strategy to capture early gains from high-profile private companies before they hit public markets, a tactic increasingly popular amidst surging investor appetite for disruptive innovation.

Editorial Team1 min
SpaceX Mania Hits ETFs: XOVR Raises Stake Ahead Of Blockbuster IPO
Technology 5/22/2026

Scientists Identify Atomic Trick That Keeps Gold Shiny

Scientists have pinpointed the precise atomic mechanism responsible for gold's famed inertness and enduring luster. Researchers, often pointing to work at institutions like the University of California, Irvine, utilized advanced computational chemistry to reveal that quantum relativistic effects on gold atoms’ outermost electrons prevent them from readily oxidizing or corroding. This means the 5d and 6s valence electrons are unusually stable and tightly bound, resisting chemical reactions that would tarnish other metals. This deep dive into quantum mechanics explains why gold, unlike most other metals, doesn’t react with oxygen or sulfur in the atmosphere, preserving its iconic sheen for millennia.

Editorial Team1 min
Scientists Identify Atomic Trick That Keeps Gold Shiny
Technology 5/22/2026

The Clean Energy Everyone Loves Can’t Power AI. Here’s What Can

The exponential growth of Artificial Intelligence (AI) has thrust its enabling infrastructure – the colossal AI data centers – into the spotlight as unprecedented energy consumers. Big Tech titans like Microsoft, Google, and Amazon are grappling with the imperative to power these facilities sustainably and reliably, leading to a significant pivot towards advanced nuclear energy. While conventional clean energy sources like solar and wind are crucial for decarbonization, their inherent intermittency renders them inadequate for the 24/7, high-load demands of AI workloads, which require constant, dispatchable baseload power to maintain operational integrity and computational throughput.

Editorial Team1 min
The Clean Energy Everyone Loves Can’t Power AI. Here’s What Can
Technology 5/21/2026

Microsoft warns of new Defender zero-days exploited in attacks - BleepingComputer

Microsoft has urgently warned of two new "zero-day" vulnerabilities, identified as UnDefend (CVE-2024-21338) and RedSun (CVE-2024-21339), within its widely used Defender antivirus software. These critical flaws, which permit "elevation of privilege," have been actively exploited by "threat actors" in targeted attacks. The revelation came as part of Microsoft's regular "Patch Tuesday" cycle, where the tech giant released security updates to mitigate these and other vulnerabilities. Given Defender's pervasive deployment across Windows ecosystems, these exploits represent a significant immediate risk to individual and organizational cybersecurity postures globally.

Editorial Team1 min
Microsoft warns of new Defender zero-days exploited in attacks - BleepingComputer
Technology 5/21/2026

SpaceX plans for a record-breaking IPO

SpaceX, the groundbreaking aerospace manufacturer and space transport services company led by Elon Musk, has reportedly confirmed plans for a monumental Initial Public Offering (IPO). This move would see the private behemoth sell Shares of its stock to the public for the very first time, an event that NBC News' David Ingram suggests could be record-breaking given the company's colossal private Valuation. This development signals a significant shift for a company known for its closely held ownership structure, offering a rare opportunity for institutional and Retail Investors alike to gain direct exposure to its ambitious ventures.

Editorial Team1 min
SpaceX plans for a record-breaking IPO
‹ Prev1…4546474849…52Next ›

Page 47 of 52 · 1029 articles

ACUMEN

Context-first journalism for a world overwhelmed by noise.

Get the App

Download for Android

Coverage

  • World
  • National
  • Technology
  • Economy
  • Culture
  • Newsletter

Company

  • About
  • Press
  • Ethics Policy
© 2026 Acumen News. All rights reserved.
PrivacyTermsCookies